IMCR vs SPCE · rev $222.6M vs rev $361.0K
Immunocore Holdings Ltd (IMCR) versus Virgin Galactic Holdings Inc (SPCE) — a side-by-side from cached financials, not a winner call.
Immunocore Holdings Ltd (IMCR) is a biotechnology company listed on NASDAQ.
Virgin Galactic Holdings Inc (SPCE) is a aerospace & defense company listed on NYSE.
Latest reported IMCR revenue for 2026-06-30 was $222.6M. Net income was $12.2M. IMCR currently screens at market cap $1.45B.
Latest reported SPCE revenue for 2026-06-30 was $361.0K. Net income was -$120.6M. Revenue was up 59.0% from 2026-03-31 to 2026-06-30. SPCE currently screens at market cap $388.0M.
IMCR currently screens at market cap $1.45B. SPCE currently screens at market cap $388.0M.
Not investment advice. Open the IMCR and SPCE stock pages for the full models.
Not investment advice.